Literature DB >> 12030579

High levels of nitric oxide synthase activity are associated with nasal polyp tissue from aspirin-sensitive asthmatics.

A Parikh1, G K Scadding, P Gray, M G Belvisi, J A Mitchell.   

Abstract

The pathogenesis of aspirin intolerance remains unclear. Inducible nitric oxide synthase (iNOS) expression is upregulated in nasal polyp epithelium, implying a role for nitric oxide (NO) in its formation. We decided to compare iNOS activity in polyp tissue from patients with and without aspirin intolerance. Nasal polyp tissue was collected from 15 patients undergoing routine nasal polypectomy. These patients were classified into three groups: Group A comprised patients with nasal polyps without asthma; Group B contained patients with nasal polyps and asthma; and Group C comprised patients with nasal polyps, asthma and aspirin sensitivity. All subjects in Group C had a history of aspirin-induced reaction and a confirmatory intranasal challenge with lysine-aspirin. NOS activity was measured by the ability of tissue homogenates to convert 3,4-L-arginine to L-citrulline in an L-N(G)-nitro-L-arginine-inhibitable fashion. The iNOS activity (picomoles) in polyp tissue from the 3 groups was: A, 248.72+/-220.79; B, 23.71+/-41.06; and C, 549.71+/-132.11. Thus, nasal polyps from patients with Samter's triad had a significantly higher iNOS activity (p = 0.004; one-way ANOVA). This finding does not correlate simply with disease severity or with the occurrence of asthma and could indicate another important facet of aspirin-induced airways disease.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12030579     DOI: 10.1080/000164802753648204

Source DB:  PubMed          Journal:  Acta Otolaryngol        ISSN: 0001-6489            Impact factor:   1.494


  7 in total

1.  Diagnostic tools in Rhinology EAACI position paper.

Authors:  Glenis Scadding; Peter Hellings; Isam Alobid; Claus Bachert; Wytske Fokkens; Roy Gerth van Wijk; Philippe Gevaert; Josep Guilemany; Livije Kalogjera; Valerie Lund; Joaquim Mullol; Giovanni Passalacqua; Elina Toskala; Cornelius van Drunen
Journal:  Clin Transl Allergy       Date:  2011-06-10       Impact factor: 5.871

2.  The effect of corticosteroid therapy on cyclooxygenase 2, vascular endothelial growth factor, and inducible nitric oxide synthase expression levels in nasal polyposis.

Authors:  Demet Yazici; Ülkü Tuncer; Aysun Uğuz
Journal:  Eur Arch Otorhinolaryngol       Date:  2014-06       Impact factor: 2.503

Review 3.  Advances in anti-IgE therapy.

Authors:  Arzu Didem Yalcin
Journal:  Biomed Res Int       Date:  2015-05-05       Impact factor: 3.411

Review 4.  An overview of the effects of anti-IgE therapies.

Authors:  Arzu Didem Yalcin
Journal:  Med Sci Monit       Date:  2014-09-22

5.  COX-1, and not COX-2 activity, regulates airway function: relevance to aspirin-sensitive asthma.

Authors:  Louise S Harrington; Ruth Lucas; Shaun K McMaster; Laura Moreno; Glenis Scadding; Timothy D Warner; Jane A Mitchell
Journal:  FASEB J       Date:  2008-08-27       Impact factor: 5.191

6.  Differential expression of tumor necrosis factor α, interleukin 1β, nuclear factor κB in nasal mucosa among chronic rhinosinusitis patients with and without polyps.

Authors:  Danuta Plewka; Alicja Grzanka; Elzbieta Drzewiecka; Andrzej Plewka; Maciej Misiołek; Grażyna Lisowska; Beata Rostkowska-Nadolska; Radoslaw Gawlik
Journal:  Postepy Dermatol Alergol       Date:  2017-05-29       Impact factor: 1.837

7.  Overexpression of Inducible Nitric Oxide Synthase in Allergic and Nonallergic Nasal Polyp.

Authors:  Ahmed Adel Sadek; Soha Abdelwahab; Safaa Yehia Eid; Riyad A Almaimani; Mohammad A Althubiti; Mahmoud Zaki El-Readi
Journal:  Oxid Med Cell Longev       Date:  2019-11-07       Impact factor: 6.543

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.